Killing Hepatocellular Carcinoma in the NAFLD/NASH Stage: A Comprehensive Perspective on Targeting Regulated Cell Death

Scientists summarize the current progress in understanding the role of regulated cell death in regulated cell death (NAFLD)/Non-alcoholic steatohepatitis (NASH) and associated HCC, explore potential therapeutic strategies and clinical applications, and provide new perspectives and therapeutic targets for treating NAFLD/NASH.